Purchase Order HT940624P0032
Award Date 1/1/24
Potential Completion Date 1/1/24
Potential Value $67K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Concord, CA 94520, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a Firm Fixed Price, $186,048.00 purchase order contract to Cerus Corporation, a biomedical products manufacturer, for the drop shipment of medical supplies. The contract is sole source and not set aside. The supplies include the INTERCEPT Blood System technology, which uses riboflavin and UV light to inactivate pathogens in blood platelets and plasma. Cerus has received over 20 federal contract awards since 2002 from agencies such as the Department of Defense,...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract, valued at $14,924.64, is for the provision of INTERCEPT Blood System equipment, illuminator maintenance services, and specialized pathogen reduction technology products. The contract has a performance period ending on June 7, 2025. Cerus...
- This is a $133,640.00 firm fixed price purchase order awarded by the Defense Health Agency to Cerus Corporation, a small business manufacturer of biomedical products. The contract is for the provision of illuminator equipment and related maintenance services, with a completion date of October 24, 2019. Cerus has received over 20 previous federal contracts from agencies including the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services to provide...
- This contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract is for the procurement of Cerus Intercept Platelet Pathogen Reduction Sets, which use a chemical agent and ultraviolet light to inactivate pathogens in blood products, primarily platelets and plasma. The contract is a firm-fixed-price purchase order with a ceiling value of $258,240.00 and a period...
- The Defense Health Agency awarded Cerus Corporation a firm fixed-price purchase order valued at $367.1K on October 1, 2025, for Cerus Intercept Platelet Processing Sets. The contract, which has no set-aside designation, originated from a sources sought notice posted by Tripler Army Medical Center seeking specialized blood processing equipment utilizing the INTERCEPT Blood System technology. This system employs amotosalen, a photoactive compound that uses UVA illumination to inactivate...
- The Defense Health Agency awarded a $199,584 firm fixed-price purchase order to Cerus Corporation on January 5, 2024, for the procurement of Intercept Platelet Sets (PN INT2140B). The contract, which extends through September 30, 2028, will be performed at Cerus Corporation's facility in Concord, California. This award represents a continuation of the established relationship between the Defense Health Agency and Cerus Corporation for blood safety technologies, with no set-aside designation...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The $138,800 firm-fixed-price contract is for the supply of INTERCEPT Illuminator 60 Hz equipment and INTERCEPT Platelet Processing Sets with Dual Storage, as well as related services, to support the agency's blood product safety requirements. Cerus Corporation's proprietary INTERCEPT Blood System uses...
- The Defense Health Agency (DOD) awarded a $367,504.80 firm fixed price purchase order to Cerus Corporation to provide INTERCEPT Platelet Processing and Service Maintenance for the Walter Reed National Military Center in Bethesda, Maryland from January 13, 2022 through January 31, 2027. Cerus Corporation will supply its INTERCEPT Blood System for platelets, which utilizes ultraviolet light and riboflavin to inactivate pathogens in platelet components during the collection and storage process,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for the maintenance of INTERCEPT Blood System illuminators, which are used to inactivate pathogens in blood components. The contract has a ceiling value of $45,898.00 and a period of performance from September 27, 2024, to September 26, 2027. Cerus Corporation is the prime contractor, and there are no...
- This is a firm-fixed price purchase order awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Cerus Corporation, a biomedical company specializing in blood safety technologies and pathogen reduction systems. The $82,389 contract is for the supply of INTERCEPT Illuminator 60 Hz systems and associated maintenance services. The illuminators are essential components of Cerus Corporation's proprietary INTERCEPT Blood System,...